Even as the market cools, opportunities for growth remain
We’ve watched over the last two years as the pandemic accelerated the ongoing shift to personalized, value-based, and technology-driven healthcare—changes that helped push M&A and investment in the sector to record highs.
Yet with the economic picture darkening, the first few months of 2022 have seen a dip in deal activity. Meanwhile, the labor shortage continues to hit healthcare and life sciences companies especially hard—burnout, increasing demand for workers, and wage pressures are intensifying.
What does the future hold? In our Quarterly Executive Poll, industry executives weighed in specifically on two areas that will have a significant impact on organizations’ future success: vertically integrated payer-provider groups and the industry’s challenges in activating digital strategies.
As the industry transitions to value-based care models, alignments between payers, providers, and health tech companies around quality and cost savings offer natural advantages as organizations look to take on and manage risk. It’s no surprise, then, that when asked whether vertically integrated payer-provider groups are the future of healthcare, nearly 60% of H&LS respondents said yes.
Heightened antitrust scrutiny may explain why some respondents thought otherwise: Last July, the Biden Administration instructed the Federal Trade Commission to review past and proposed mergers to address price increases and other potential impacts from consolidation.
Technology is increasingly important, whether it’s being used to deliver more personalized customer experiences, improve organizations’ bottom lines, or drive virtual modes of care and better health outcomes. Emerging health-tech companies raised nearly $40 billion last year, more than double that of 2020.
Our poll, however, shows the industry still faces several obstacles in activating such strategies. Challenges include attracting and retaining the talent needed to develop or support digital health (34%), lack of industry consensus on what “digital health” is and how it should work (32%), and lack of alignment between business and tech priorities (18%).
In other words, taken together, an entire 84% of respondents indicated that the industry is facing fundamental misalignments when it comes to digital health. This dramatically underscores the need we see for redirecting some of the attention away from fancy technologies and focusing on conceptual and operational readiness to bring those technologies in the healthcare fold. Only in this way will those technologies make the impacts they’re designed to make—and make them continuously over time.
In an increasingly competitive landscape, healthcare organizations will need to become more and more digital, data-driven, analytical, and interconnected. It’s this digital thrust that connects West Monroe’s three key focus areas for the year to come:
Adopting Digital Mindsets: Where Healthcare Stakeholders Are Succeeding and Where They’re Falling Short
Rising to the Occasion: What Patient Centricity Means in Life Sciences and How to Achieve It